Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Clinical Briefings™: Examining the Role of CGRPs for the Treatment of Cluster Headaches

Release Date: March 27, 2020
Expiration Date: March 27, 2021
Media: Internet - based

Activity Overview

This online activity is designed to provide a concise and focused overview on an important clinical topic and includes information on disease burden, the role of calcitonin gene-related peptide (CGRP) pathway, and clinical trial data of emerging therapies for cluster headache. The engaging, multimedia format of this program includes audio commentary from an expert thought leader integrated with text-based elements.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This online educational activity is directed toward neurologists, primary care physicians, nurse practitioners (NPs), physician assistants (PAs), nurses and other health care professionals who would be involved in the diagnosis and management of headache disorders.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Identify unmet patient needs and the burden of cluster headache
  • Review the role of the CGRP pathway in the pathophysiology of cluster headache
  • Evaluate the safety and efficacy data from clinical trials of new and emerging therapies in treatment of patients with cluster headaches

Faculty, Staff, and Planners’ Disclosures

Faculty

Stephen D. Silberstein, MD, FAHS, FAAN, FACP
Stephen D. Silberstein, MD, FAHS, FAAN, FACP
Director
Professor of Neurology
Jefferson Headache Center
Philadelphia, PA

Disclosures: Consultant/ advisory panel member: Abide Therapeutics; Alder BioPharmaceuticals; Allergan, Inc.; Amgen; Avanir Pharmaceuticals, Inc.; Biohaven Pharmaceuticals; CEFALY Technology; Curelator, Inc.; Dr. Reddy’s Laboratories; Egalet Corporation; GlaxoSmithKline Consumer Healthcare Holdings, LLC.; eNeura Inc.; electroCore, Inc; Impel NeuroPharma, Inc.; Eli Lilly and Company; Medscape, LLC; Novartis, Inc.; Satsuma Pharmaceuticals; Supernus Pharmaceuticals, Inc.; Teva Pharmaceuticals; Theranica; Trigemina, Inc.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI.

Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent clinical judgment of a physician relative to diagnostic or treatment options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or the company that provided commercial support.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
      1
2345678
9101112131415
16171819202122
23242526272829
3031
Filter By